xanthine/inflammation

Länken sparas på Urklipp

Välj sorteringstyp

Sida 1 från 17 resultat

Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention relates to novel pharmaceutical compositions of matter comprising xanthines and one or more analgesic agents, or xanthines and an anti-inflammatory agent, and to methods of using said compositions to hasten the onset of an analgesic or anti-inflammatory

Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TECHNICAL FIELD OF THE INVENTION The invention relates to a discovery that an isomer of a hydroxy-substituted xanthine compound is an effective agent to modulate cellular responses to stimuli mediated through a stereo-specific cellular second messenger pathway. More specifically, the inventive

Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention relates to a pharmaceutical product for the treatment of conditions associated with elevated levels of tumour necrosis factor-.alpha. (herein referred to as TNF) and to the manufacture of such a product. The pharmaceutical product may, for example, be

Method of using pentoxifylline for treating inflammation

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

It is known that 1-(5-oxohexyl)-3,7-dimethylxanthine (pentoxifylline) is used as a pharmaceutical agent for the improvement of the flow properties of blood. The supposed cause of this is (Deutsche mediz, Wochenschrift 107 (1982), 1674) that the viscous stress of the blood decreases because the

Novel xanthine derivatives

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to novel xanthine derivatives having pharmaceutical utility, processes for their production, pharmaceutical compositions comprising them and their use as pharmaceuticals. More particularly the present invention provides: a compound of formula I ##STR2## wherein R.sub.1

Phenyl xanthine derivatives

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention relates to glycol derivatives of xanthines, processes for their preparation, pharmaceutical formulations comprising them, and their use in medicine, particularly in the treatment and prophylaxis of inflammatory conditions, immune disorders, septic shock,

Pyrazole derivative

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/JP2014/059912 filed Mar. 28, 2014, claiming priority based on Japanese Patent Application No. 2013-072788 filed Mar. 29, 2013, the contents of all of which are incorporated herein by

2-aryl selenazole compound and pharmaceutical composition thereof

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

This application is the U.S. national phase of International Application No. PCT/CN2013/087736 Filed on 24 Nov. 2013 which designated the U.S. and claims priority to Chinese Application Nos. CN201210504310.8 filed on 30 Nov. 2012, the entire contents of each of which are hereby incorporated by

Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention provides a method for optimizing therapeutic efficacy and predicting tolerance of 6-mercaptopurine (6-MP) drug treatment, especially in an immune-mediated gastrointestinal disorder. BACKGROUND OF THE INVENTION Mercaptopurine (6-MP or 6-thiopurine) and

Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

Method for the preventing and/or treating IL-1 beta lung pathology in mammals by administering a uric acid reducing compound

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

This application is a U.S. National Stage application of PCT/EP2009/062159, filed Sept. 18, 2009, which claims priority to European Patent Application No. 083055657, filed Sept. 18, 2008, each and all of which are incorporated herein by reference in their entirety. The present invention is directed

Cosmetic preparation with a peptide addition

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention concerns a new cosmetic preparation containing peptide derivatives derived from .alpha.-MSH (melanocyte stimulating hormone) and other active ingredients. 2. The Prior Art .alpha.-MSH has already been investigated by a number of

2-phenylpyridine derivative

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

This is a national stage application under 35 U.S.C. .sctn.371 of PCT/JP2005/015549 filed on Aug. 26, 2005, which claims priority from Japanese patent application P.2004-249275 filed on Aug. 27, 2004 and from Japanese patent application P.2005-078222 filed on Mar. 17, 2005, all of which are

2-phenylthiophene derivative

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TECHNICAL FIELD The present invention relates to a 2-phenylthiophene derivative useful as a medicament, particularly a therapeutic or preventive agent for diseases in which xantine oxidase participates, such as hyperuricemia, gout, inflammatory bowel diseases, diabetic kidney diseases, and diabetic

Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

TECHNICAL FIELD This invention describes a nutritional composition and method of use for prevention of Parkinson's disease, therefore relating to the fields of nutrition, pharmacology, neurology, pathophysiology, medicine and movement disorders. DESCRIPTION OF THE RELATED ART Parkinson's disease

Tidigare
1
2
Nästa

Gå med på vår
facebook-sida

Herbal & Natural Medicine

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning